Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P de Cremoux

Showing results (41-50 of 59) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|January 11, 2007
Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanismsM-E Legrier, S Oudard, J-G Judde, et al.
European Urology|January 1, 1997
Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomyP de Cremoux, V Ravery, M P Podgorniak, et al.
Endocrine-Related Cancer|September 17, 2004
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reactionP de Cremoux, I Bieche, C Tran-Perennou, et al.
British Journal of Cancer|April 25, 2013
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumabM Cizkova, M-E Dujaric, J Lehmann-Che, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Hepatitis C virus infection and MALT-type ocular adnexal lymphomaP Arnaud, M-C Escande, M Lecuit, et al.
Bulletin Du Cancer|February 13, 2009
[Circulating tumor cells and breast cancer: detection techniques and clinical results]F-C Bidard, A-E Saliba, L Saias, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Circulating tumor cell detection and transcriptomic profiles in early breast cancer patientsF Reyal, F Valet, P de Cremoux, et al.
International Journal of Cancer|March 12, 1998
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancerS Rozan, A Vincent-Salomon, B Zafrani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapyF-C Bidard, C Mathiot, A Degeorges, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2018
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancerDavid Groheux, L Biard, J Lehmann-Che, et al.
Pageof 6

Showing results (41-50 of 59) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|January 11, 2007
Potentiation of antitumour activity of docetaxel by combination with trastuzumab in a human prostate cancer xenograft model and underlying mechanismsM-E Legrier, S Oudard, J-G Judde, et al.
European Urology|January 1, 1997
Value of the preoperative detection of prostate-specific-antigen-positive circulating cells by nested RT-PCR in patients submitted to radical prostatectomyP de Cremoux, V Ravery, M P Podgorniak, et al.
Endocrine-Related Cancer|September 17, 2004
Inter-laboratory quality control for hormone-dependent gene expression in human breast tumors using real-time reverse transcription-polymerase chain reactionP de Cremoux, I Bieche, C Tran-Perennou, et al.
British Journal of Cancer|April 25, 2013
Outcome impact of PIK3CA mutations in HER2-positive breast cancer patients treated with trastuzumabM Cizkova, M-E Dujaric, J Lehmann-Che, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 27, 2006
Hepatitis C virus infection and MALT-type ocular adnexal lymphomaP Arnaud, M-C Escande, M Lecuit, et al.
Bulletin Du Cancer|February 13, 2009
[Circulating tumor cells and breast cancer: detection techniques and clinical results]F-C Bidard, A-E Saliba, L Saias, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 29, 2011
Circulating tumor cell detection and transcriptomic profiles in early breast cancer patientsF Reyal, F Valet, P de Cremoux, et al.
International Journal of Cancer|March 12, 1998
No significant predictive value of c-erbB-2 or p53 expression regarding sensitivity to primary chemotherapy or radiotherapy in breast cancerS Rozan, A Vincent-Salomon, B Zafrani, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 18, 2010
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapyF-C Bidard, C Mathiot, A Degeorges, et al.
European Journal of Nuclear Medicine and Molecular Imaging|April 5, 2018
Tumor metabolism assessed by FDG-PET/CT and tumor proliferation assessed by genomic grade index to predict response to neoadjuvant chemotherapy in triple negative breast cancerDavid Groheux, L Biard, J Lehmann-Che, et al.
Pageof 6